Monopar Therapeutics Stock (NASDAQ: MNPR) stock price, news, charts, stock research, profile.
Open | $0.701 |
Close | $0.681 |
Volume / Avg. | 290.922K / 5.385M |
Day Range | 0.640 - 0.735 |
52 Wk Range | 0.274 - 2.980 |
Market Cap | $10.243M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 47 |
Short Interest | 3.58% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.
Other companies in Monopar Therapeutics’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Virios Therapeutics (NASDAQ:VIRI), Imunon (NASDAQ:IMNN), Addex Therapeutics (NASDAQ:ADXN) and Evaxion Biotech (NASDAQ:EVAX).
The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by HC Wainwright & Co. on Thursday, June 1, 2023. The analyst firm set a price target for 17.00 expecting MNPR to rise to within 12 months (a possible 2367.34% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $0.689 last updated March 28, 2024 at 4:43 PM EDT.
There are no upcoming dividends for Monopar Therapeutics.
Monopar Therapeutics’s Q3 earnings are confirmed for Friday, November 11, 2022.
There is no upcoming split for Monopar Therapeutics.
Monopar Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.